Comparative Analysis of Predictive Biomarkers for PD-1/PD-L1 Inhibitors in Cancers: Developments and Challenges

SIMPLE SUMMARY: The development of immune checkpoint inhibitors (ICIs) has greatly changed the treatment landscape of multiple malignancies. However, the wide administration of ICIs is mainly obstructed by the low response rate and several life-threatening adverse events. Thus, there is an urgent ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Fang, Wang, Jacqueline F., Wang, Yucai, Liu, Baorui, Molina, Julian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750062/
https://www.ncbi.nlm.nih.gov/pubmed/35008273
http://dx.doi.org/10.3390/cancers14010109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750062/
https://www.ncbi.nlm.nih.gov/pubmed/35008273
http://dx.doi.org/10.3390/cancers14010109

Ejemplares similares